Lawyer Monthly | Interview with Raphaël Chantelot and Mathieu Selva-Roudon about Vivalto Partners’ equity investment in Laboratoires Delbert

Lawyer Monthly | Interview with Raphaël Chantelot and Mathieu Selva-Roudon about Vivalto Partners’ equity investment in Laboratoires Delbert

In Mai 2023, LPA-CGR avocats advised Laboratoires Delbert on Vivalto Partners’ acquisition of a stake in its business. This Parisian laboratory founded in 2002  specialises in the acquisition and maintenance of major and essential drugs as identified by the World Health Organisation. Laboratoires Delbert is best known for its expertise in securing production chains, limiting supply disruption risk and acting as a reference partner for regulatory authorities and large pharmaceutical firms. LPA-CGR avocats advised Laboratoires Delbert on this secondary LBO with a team comprising partners Raphaël Chantelot and Mathieu Selva-Roudon, as well as associates Maxime Ponsan, Céline Guo and Déborah Théry.

Lawyer Monthly had the pleasure to speak with Raphaël Chantelot and Mathieu Selva-Roudon, Partners at LPA-CGR avocats to give some further insight into this transaction.

Discover the interview and learn about other services LPA-CGR avocats offers in the healthcare sector!